Global Immunoprotein Diagnostic Testing Market to Reach US$15.35 bn by 2019 Aided by Growing Need for Preventive Healthcare

Transparency Market Research has published a new report on the global immunoprotein diagnostic testing market. According to the report, the global immunoprotein diagnostic testing market stood at US$11.02 bn in 2012 and is expected to reach US$15.35 bn by 2019, progressing at a 5.70% CAGR from 2013 to 2019. The report, titled ‘Immunoprotein Diagnostic Testing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019,’ states that the global immunoprotein diagnostic testing market is expected to expand rapidly due to the commoditization of products, the rising need for quick diagnosis of diseases, and the increasing demand for preventive healthcare in developing nations.

Browse the full Immunoprotein Diagnostic Testing Market (Radioimmunoassay, Enzyme Based Immunoassay, Chemiluminescence Assay, Immunofluorescence Assay, Immunoturbidity Assayand Immunoprotein Electrophoresis) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019 report at http://www.transparencymarketresearch.com/immunoprotein-diagnostic-testing.html

Immunoproteins are a part of the body’s defense mechanism and show characteristic serum concentration under certain abnormal conditions. The concentration of immunoproteins has been a major indicator for the diagnosis of a diseased state. When exposed to an antigen, the level of immunoproteins increases 10- to 100-fold within 24 to 48 hours. The applications of immunoproteins have shifted from microbial testing to rapid testing.

Technological advancements and a strong network of distributors are two of the important factors expected to drive the global immunoprotein diagnostic testing market in the years to come. The higher cost of immunoprotein-based diagnosis and the existing installed base of traditional ELISA are predicted to restrict the growth of the global immunoprotein diagnostic testing market. However, improved research and development activities, expansion of the technique in emerging economies, and the uptake of immunochromatography are predicted to create growth opportunities in the global immunoprotein diagnostic testing market in the near future.

The global immunoprotein diagnostic testing market is segmented on the basis of immunoprotein type, geography, application, and assay technology. Based on type, the global immunoprotein diagnostic testing market is classified into free light chain diagnostic tests, C-reactive protein diagnostic tests, immunoglobulin diagnostic tests, complement system protein diagnostic tests, and haptoglobin diagnostic tests. Currently, the global immunoprotein diagnostic testing market is dominated by the C-reactive protein diagnostic test segment due to its accurate and effective diagnosis of inflammation-related disorders, injuries, cardiovascular diseases, and strokes.

By technology, the global immunoprotein diagnostic testing market is classified into enzyme-based immunoassay, chemiluminescence assay, immunoprotein electrophoresis, immunoturbidity, and radioimmunoassay. The global immunoprotein diagnostic testing market, in 2012, was dominated by the chemiluminescence assay segment due to its ease of use, safety, and feasibility in various conditions. Some of the applications of immunoprotein diagnostic testing are in toxicology testing, autoimmune disease testing, endocrine testing, infectious diseases, allergy testing, and oncology testing. The oncology testing segment is predicted to reach US$4.94 bn by 2019, and is expected to expand at a 6.0% CAGR from 2013 to 2019.

Download Exclusive Brochure of This Report

http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1253

Based on geography, the global immunoprotein diagnostic testing market is divided into Europe, Asia Pacific, North America, and the Rest of the World. DiaSorin SPA, The Binding Site Group Ltd., Omega Diagnostics Group PLC, Siemens AG, Roche Holding AG, Abbott Laboratories, Inc., Thermo Fisher Scientific, Inc., Abcam PLC, Randox Laboratories Ltd., Enzo Life Sciences, Inc., and Fujirebio Diagnostics, Inc. are some of the prominent companies in the global immunoprotein diagnostic testing market.

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

Contact

Mr.Sudip S
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.